Common Stocks - 98.1%
|
|||
Shares
|
Value ($)
|
||
COMMUNICATION SERVICES - 9.8%
|
|||
Entertainment - 1.1%
|
|||
Electronic Arts, Inc.
|
3,154
|
439,920
|
|
Netflix, Inc. (a)
|
243,229
|
146,647,629
|
|
Roblox Corp. (a)
|
164,900
|
6,579,510
|
|
Roku, Inc. Class A (a)
|
83,776
|
5,292,968
|
|
The Walt Disney Co.
|
70,776
|
7,897,186
|
|
166,857,213
|
|||
Interactive Media & Services - 8.4%
|
|||
Alphabet, Inc.:
|
|||
Class A (a)
|
4,137,580
|
572,889,327
|
|
Class C (a)
|
2,439,260
|
340,959,763
|
|
Epic Games, Inc. (a)(b)(c)
|
11,800
|
8,095,508
|
|
IAC, Inc. (a)
|
8,100
|
460,080
|
|
Meta Platforms, Inc. Class A
|
783,330
|
383,933,533
|
|
Snap, Inc. Class A (a)
|
1,841,781
|
20,296,427
|
|
1,326,634,638
|
|||
Media - 0.0%
|
|||
Comcast Corp. Class A
|
18,700
|
801,295
|
|
The Trade Desk, Inc. (a)
|
7,100
|
606,553
|
|
1,407,848
|
|||
Wireless Telecommunication Services - 0.3%
|
|||
T-Mobile U.S., Inc.
|
307,853
|
50,272,395
|
|
TOTAL COMMUNICATION SERVICES
|
1,545,172,094
|
||
CONSUMER DISCRETIONARY - 18.2%
|
|||
Automobiles - 1.1%
|
|||
Neutron Holdings, Inc. (a)(b)(c)
|
438,358
|
14,290
|
|
Rad Power Bikes, Inc. (a)(b)(c)
|
249,183
|
107,149
|
|
Rad Power Bikes, Inc. warrants 10/6/33 (a)(b)(c)
|
181,375
|
428,045
|
|
Rivian Automotive, Inc. (a)(d)
|
2,141,919
|
24,246,523
|
|
Tesla, Inc. (a)
|
703,705
|
142,063,965
|
|
166,859,972
|
|||
Broadline Retail - 6.9%
|
|||
Amazon.com, Inc. (a)
|
5,850,660
|
1,034,162,662
|
|
Etsy, Inc. (a)
|
19,281
|
1,382,255
|
|
Ollie's Bargain Outlet Holdings, Inc. (a)
|
700,187
|
56,133,992
|
|
PDD Holdings, Inc. ADR (a)
|
17,300
|
2,154,542
|
|
1,093,833,451
|
|||
Diversified Consumer Services - 0.0%
|
|||
Duolingo, Inc. (a)
|
11,800
|
2,820,200
|
|
Hotels, Restaurants & Leisure - 1.1%
|
|||
Airbnb, Inc. Class A (a)
|
59,600
|
9,385,212
|
|
Booking Holdings, Inc.
|
19,572
|
67,891,941
|
|
Cava Group, Inc.
|
9,300
|
543,213
|
|
Chipotle Mexican Grill, Inc. (a)
|
10,535
|
28,326,192
|
|
Dutch Bros, Inc. (a)
|
142,600
|
4,153,938
|
|
Expedia, Inc. (a)
|
40,800
|
5,582,256
|
|
Hyatt Hotels Corp. Class A
|
5,083
|
780,698
|
|
Marriott International, Inc. Class A
|
74,850
|
18,702,770
|
|
McDonald's Corp.
|
3,525
|
1,030,287
|
|
Penn Entertainment, Inc. (a)
|
620,300
|
11,351,490
|
|
Shake Shack, Inc. Class A (a)
|
21,536
|
2,289,708
|
|
Sonder Holdings, Inc.:
|
|||
Stage 1 rights (a)(c)
|
14,240
|
142
|
|
Stage 2 rights (a)(c)
|
14,240
|
0
|
|
Stage 3 rights (a)(c)
|
14,239
|
0
|
|
Stage 4 rights (a)(c)
|
14,239
|
0
|
|
Stage 5:
|
|||
rights (a)(c)
|
14,238
|
0
|
|
rights (a)(c)
|
14,238
|
0
|
|
Starbucks Corp.
|
88,153
|
8,365,720
|
|
Sweetgreen, Inc. Class A (a)
|
331,102
|
4,218,239
|
|
Zomato Ltd. (a)
|
2,843,600
|
5,675,537
|
|
168,297,343
|
|||
Household Durables - 0.4%
|
|||
Garmin Ltd.
|
74,300
|
10,205,105
|
|
Lennar Corp. Class A
|
263,219
|
41,722,844
|
|
SharkNinja Hong Kong Co. Ltd.
|
53,800
|
2,905,200
|
|
Toll Brothers, Inc.
|
32,200
|
3,691,408
|
|
58,524,557
|
|||
Leisure Products - 0.0%
|
|||
Peloton Interactive, Inc. Class A (a)(d)
|
26,242
|
118,614
|
|
Specialty Retail - 2.5%
|
|||
Abercrombie & Fitch Co. Class A (a)
|
63,000
|
8,048,880
|
|
Dick's Sporting Goods, Inc.
|
46,621
|
8,293,410
|
|
Fanatics, Inc. Class A (a)(b)(c)
|
180,405
|
12,918,802
|
|
Five Below, Inc. (a)
|
14,300
|
2,869,724
|
|
Floor & Decor Holdings, Inc. Class A (a)(d)
|
71,900
|
8,708,528
|
|
Foot Locker, Inc.
|
135,400
|
4,661,822
|
|
Lowe's Companies, Inc.
|
248,873
|
59,896,265
|
|
Revolve Group, Inc. (a)(d)
|
501,723
|
11,002,785
|
|
RH (a)
|
7,929
|
2,175,718
|
|
Ross Stores, Inc.
|
54,100
|
8,058,736
|
|
RumbleON, Inc. Class B (a)(d)
|
154,000
|
1,168,860
|
|
The Home Depot, Inc.
|
256,177
|
97,503,528
|
|
TJX Companies, Inc.
|
957,672
|
94,943,602
|
|
Wayfair LLC Class A (a)(d)
|
1,178,370
|
70,230,852
|
|
390,481,512
|
|||
Textiles, Apparel & Luxury Goods - 6.2%
|
|||
Birkenstock Holding PLC (d)
|
85,100
|
4,255,851
|
|
Canada Goose Holdings, Inc. (a)(d)
|
462,715
|
6,304,093
|
|
Crocs, Inc. (a)
|
43,900
|
5,366,775
|
|
Deckers Outdoor Corp. (a)
|
188,962
|
169,232,478
|
|
Figs, Inc. Class A (a)(d)
|
73,900
|
386,497
|
|
Li Ning Co. Ltd.
|
433,500
|
1,080,774
|
|
lululemon athletica, Inc. (a)
|
1,312,758
|
613,176,134
|
|
NIKE, Inc. Class B
|
232,554
|
24,169,337
|
|
On Holding AG (a)(d)
|
1,457,806
|
51,052,366
|
|
Skechers U.S.A., Inc. Class A (sub. vtg.) (a)
|
1,613,762
|
99,746,629
|
|
Tory Burch LLC (a)(b)(c)(e)
|
248,840
|
9,234,452
|
|
984,005,386
|
|||
TOTAL CONSUMER DISCRETIONARY
|
2,864,941,035
|
||
CONSUMER STAPLES - 2.6%
|
|||
Beverages - 1.1%
|
|||
Celsius Holdings, Inc. (a)(d)
|
257,600
|
21,025,312
|
|
Constellation Brands, Inc. Class A (sub. vtg.)
|
9,800
|
2,435,496
|
|
Keurig Dr. Pepper, Inc.
|
508,171
|
15,199,395
|
|
Monster Beverage Corp.
|
723,070
|
42,733,437
|
|
PepsiCo, Inc.
|
142,764
|
23,604,600
|
|
The Coca-Cola Co.
|
1,084,907
|
65,116,118
|
|
170,114,358
|
|||
Consumer Staples Distribution & Retail - 0.7%
|
|||
Costco Wholesale Corp.
|
84,144
|
62,593,880
|
|
Dollar General Corp.
|
27,740
|
4,030,899
|
|
Dollar Tree, Inc. (a)
|
25,644
|
3,761,462
|
|
Kroger Co.
|
134,140
|
6,654,685
|
|
Maplebear, Inc. (NASDAQ)
|
25,545
|
831,234
|
|
Ocado Group PLC (a)
|
20,620
|
133,110
|
|
Target Corp.
|
130,313
|
19,927,464
|
|
Walmart, Inc.
|
268,800
|
15,754,368
|
|
113,687,102
|
|||
Food Products - 0.2%
|
|||
Archer Daniels Midland Co.
|
1,600
|
84,976
|
|
Bowery Farming, Inc. warrants (a)(b)(c)
|
14,699
|
60,707
|
|
Bunge Global SA
|
110,354
|
10,414,107
|
|
Kellanova
|
27,500
|
1,516,625
|
|
Mondelez International, Inc.
|
56,417
|
4,122,390
|
|
The Hershey Co.
|
30,800
|
5,787,936
|
|
The Real Good Food Co. LLC:
|
|||
Class B (a)(c)
|
131,479
|
1
|
|
Class B unit (a)(f)
|
131,479
|
152,516
|
|
The Real Good Food Co., Inc. (a)
|
133,700
|
155,092
|
|
WK Kellogg Co. (d)
|
25,200
|
368,928
|
|
22,663,278
|
|||
Household Products - 0.2%
|
|||
Church & Dwight Co., Inc.
|
34,121
|
3,416,195
|
|
Colgate-Palmolive Co.
|
32,191
|
2,785,165
|
|
Procter & Gamble Co.
|
154,378
|
24,536,839
|
|
The Clorox Co.
|
13,400
|
2,054,354
|
|
32,792,553
|
|||
Personal Care Products - 0.1%
|
|||
elf Beauty, Inc. (a)
|
34,000
|
7,090,020
|
|
Kenvue, Inc.
|
64,600
|
1,227,400
|
|
Oddity Tech Ltd.
|
22,600
|
953,268
|
|
Oddity Tech Ltd. (f)
|
34,271
|
1,445,551
|
|
The Beauty Health Co. (a)
|
1,183,498
|
3,941,048
|
|
The Beauty Health Co. (a)(b)
|
553,828
|
1,844,247
|
|
16,501,534
|
|||
Tobacco - 0.3%
|
|||
JUUL Labs, Inc. Class A (a)(b)(c)(g)
|
1,968,071
|
2,105,836
|
|
Philip Morris International, Inc.
|
546,800
|
49,190,128
|
|
51,295,964
|
|||
TOTAL CONSUMER STAPLES
|
407,054,789
|
||
ENERGY - 0.6%
|
|||
Energy Equipment & Services - 0.1%
|
|||
Baker Hughes Co. Class A
|
194,000
|
5,740,460
|
|
Halliburton Co.
|
337,300
|
11,829,111
|
|
17,569,571
|
|||
Oil, Gas & Consumable Fuels - 0.5%
|
|||
Cameco Corp. (d)
|
431,800
|
17,500,854
|
|
EOG Resources, Inc.
|
8,200
|
938,572
|
|
EQT Corp.
|
76,900
|
2,856,835
|
|
Exxon Mobil Corp.
|
5,700
|
595,764
|
|
Hess Corp.
|
94,806
|
13,817,975
|
|
Range Resources Corp.
|
654,000
|
20,679,480
|
|
Reliance Industries Ltd.
|
364,759
|
12,855,780
|
|
Valero Energy Corp.
|
41,000
|
5,799,860
|
|
75,045,120
|
|||
TOTAL ENERGY
|
92,614,691
|
||
FINANCIALS - 2.7%
|
|||
Banks - 0.4%
|
|||
Bank of America Corp.
|
646,517
|
22,317,767
|
|
HDFC Bank Ltd. sponsored ADR
|
262,722
|
14,055,627
|
|
JPMorgan Chase & Co.
|
91,223
|
16,972,951
|
|
Wells Fargo & Co.
|
143,500
|
7,977,165
|
|
61,323,510
|
|||
Capital Markets - 0.2%
|
|||
3i Group PLC
|
104,000
|
3,249,279
|
|
BlackRock, Inc. Class A
|
26,297
|
21,335,808
|
|
Coinbase Global, Inc. (a)
|
53,600
|
10,910,816
|
|
35,495,903
|
|||
Financial Services - 2.1%
|
|||
Ant International Co. Ltd. Class C (a)(b)(c)
|
570,188
|
1,020,637
|
|
Block, Inc. Class A (a)
|
70,485
|
5,601,443
|
|
Jio Financial Services Ltd.
|
511,459
|
1,912,688
|
|
MasterCard, Inc. Class A
|
282,549
|
134,142,963
|
|
PayPal Holdings, Inc. (a)
|
108,527
|
6,548,519
|
|
Saluda Medical, Inc. warrants 1/20/27 (a)(b)(c)
|
16,498
|
50,319
|
|
Toast, Inc. (a)(d)
|
642,000
|
14,766,000
|
|
Visa, Inc. Class A
|
596,112
|
168,485,096
|
|
332,527,665
|
|||
Insurance - 0.0%
|
|||
Progressive Corp.
|
17,300
|
3,279,388
|
|
TOTAL FINANCIALS
|
432,626,466
|
||
HEALTH CARE - 12.2%
|
|||
Biotechnology - 6.7%
|
|||
4D Molecular Therapeutics, Inc. (a)
|
59,100
|
1,655,982
|
|
4D Pharma PLC (a)(c)(d)
|
596,200
|
125,380
|
|
AbbVie, Inc.
|
85,949
|
15,131,321
|
|
Absci Corp. (a)(d)
|
1,100,533
|
5,678,750
|
|
ACADIA Pharmaceuticals, Inc. (a)
|
319,671
|
7,429,154
|
|
Acelyrin, Inc.
|
118,800
|
1,003,860
|
|
Akouos, Inc. (CVR) (a)(c)
|
200,563
|
166,467
|
|
Alector, Inc. (a)
|
931,389
|
6,491,781
|
|
Allogene Therapeutics, Inc. (a)
|
734,000
|
3,603,940
|
|
Alnylam Pharmaceuticals, Inc. (a)
|
371,531
|
56,134,619
|
|
Amgen, Inc.
|
113,204
|
30,998,651
|
|
Annexon, Inc. (a)
|
451,440
|
2,514,521
|
|
Apellis Pharmaceuticals, Inc. (a)
|
60,100
|
3,724,397
|
|
Apogee Therapeutics, Inc. (d)
|
301,362
|
10,493,425
|
|
Arcellx, Inc. (a)
|
7,800
|
513,396
|
|
Argenx SE ADR (a)
|
153,660
|
58,392,337
|
|
Arrowhead Pharmaceuticals, Inc. (a)
|
130,618
|
4,192,838
|
|
Ascendis Pharma A/S sponsored ADR (a)
|
9,489
|
1,402,095
|
|
aTyr Pharma, Inc. (a)
|
589,887
|
1,132,583
|
|
Avidity Biosciences, Inc. (a)
|
542,912
|
9,935,290
|
|
Avidity Biosciences, Inc. (b)
|
166,300
|
2,743,950
|
|
AVROBIO, Inc. (b)(c)(g)
|
118,919
|
1,474,486
|
|
Beam Therapeutics, Inc. (a)
|
180,700
|
7,135,843
|
|
BeiGene Ltd. ADR (a)
|
109,039
|
18,062,310
|
|
Biogen, Inc. (a)
|
1,042
|
226,104
|
|
Biomea Fusion, Inc. (a)(d)
|
514,427
|
9,002,473
|
|
BioNTech SE ADR (a)
|
6,602
|
587,314
|
|
BioXcel Therapeutics, Inc. (a)(d)
|
193,560
|
615,521
|
|
Cargo Therapeutics, Inc.
|
124,800
|
3,017,664
|
|
Caris Life Sciences, Inc. (a)(b)(c)
|
396,011
|
1,104,871
|
|
Century Therapeutics, Inc. (a)(d)
|
168,400
|
618,028
|
|
Cerevel Therapeutics Holdings (a)
|
279,359
|
11,453,719
|
|
Cibus, Inc. (a)(d)
|
237,532
|
4,142,558
|
|
Codiak Biosciences, Inc. warrants 9/15/27 (a)(c)
|
104,600
|
1
|
|
CRISPR Therapeutics AG (a)(d)
|
162,100
|
13,652,062
|
|
Cyclerion Therapeutics, Inc. (a)
|
1,910
|
6,017
|
|
Cyclerion Therapeutics, Inc. (a)(b)
|
7,527
|
23,710
|
|
Day One Biopharmaceuticals, Inc. (a)
|
198,500
|
3,320,905
|
|
Deverra Therapeutics, Inc. (a)(c)
|
20,487
|
0
|
|
Dianthus Therapeutics, Inc. (a)
|
74,098
|
1,833,926
|
|
Dianthus Therapeutics, Inc. (unlisted) (b)
|
152,986
|
3,597,083
|
|
Disc Medicine, Inc. rights (a)(c)
|
16,600
|
0
|
|
Dyne Therapeutics, Inc. (a)
|
152,900
|
4,113,010
|
|
Foghorn Therapeutics, Inc. (a)
|
184,083
|
1,422,962
|
|
Generation Bio Co. (a)
|
329,160
|
826,192
|
|
Geron Corp. (a)
|
481,500
|
963,000
|
|
Ideaya Biosciences, Inc. (a)
|
725,400
|
32,425,380
|
|
Idorsia Ltd. (a)(d)
|
121,364
|
306,309
|
|
Immunocore Holdings PLC ADR (a)
|
194,296
|
13,060,577
|
|
Immunome, Inc. (a)
|
335,097
|
8,109,347
|
|
Immunovant, Inc. (a)
|
579,500
|
20,496,915
|
|
Intarcia Therapeutics, Inc. warrants 12/6/24 (a)(c)
|
7,022
|
0
|
|
Invivyd, Inc. (a)
|
323,017
|
1,269,457
|
|
Ionis Pharmaceuticals, Inc. (a)(d)
|
1,941,569
|
87,778,334
|
|
Janux Therapeutics, Inc. (a)
|
222,020
|
10,741,328
|
|
Korro Bio, Inc. (b)
|
16,996
|
820,907
|
|
Korro Bio, Inc. (n)
|
23,257
|
1,067,147
|
|
Krystal Biotech, Inc. (a)
|
167,011
|
26,633,244
|
|
Kymera Therapeutics, Inc. (a)
|
270,359
|
11,544,329
|
|
Legend Biotech Corp. ADR (a)
|
496,150
|
32,329,134
|
|
Lyell Immunopharma, Inc. (a)(d)
|
321,900
|
939,948
|
|
Moderna, Inc. (a)
|
281,341
|
25,950,894
|
|
Monte Rosa Therapeutics, Inc. (a)
|
186,800
|
1,182,444
|
|
Moonlake Immunotherapeutics (a)
|
53,700
|
2,590,488
|
|
Morphic Holding, Inc. (a)
|
402,914
|
14,887,672
|
|
Nuvalent, Inc. Class A (a)
|
499,225
|
41,994,807
|
|
Omega Therapeutics, Inc. (a)(d)
|
479,679
|
1,971,481
|
|
ORIC Pharmaceuticals, Inc. (a)
|
79,108
|
1,007,836
|
|
Poseida Therapeutics, Inc. (a)
|
867,459
|
3,435,138
|
|
Prothena Corp. PLC (a)
|
746,505
|
20,596,073
|
|
RAPT Therapeutics, Inc. (a)
|
365,446
|
3,131,872
|
|
Recursion Pharmaceuticals, Inc. (a)(d)
|
391,600
|
5,270,936
|
|
Regeneron Pharmaceuticals, Inc. (a)
|
77,421
|
74,795,654
|
|
Relay Therapeutics, Inc. (a)(d)
|
67,600
|
677,352
|
|
Revolution Medicines, Inc. (a)
|
220,902
|
6,512,191
|
|
Roivant Sciences Ltd. (a)
|
2,772,000
|
31,711,680
|
|
Sage Therapeutics, Inc. (a)
|
458,313
|
9,844,563
|
|
Sagimet Biosciences, Inc. (d)
|
64,500
|
395,385
|
|
Sana Biotechnology, Inc. (a)(d)
|
1,065,900
|
10,701,636
|
|
Scholar Rock Holding Corp. (a)
|
660,534
|
10,238,277
|
|
Scholar Rock Holding Corp. warrants 12/31/25 (a)(b)
|
44,550
|
405,167
|
|
Seres Therapeutics, Inc. (a)(d)
|
1,557,200
|
1,775,208
|
|
Shattuck Labs, Inc. (a)
|
397,000
|
3,465,810
|
|
Sigilon Therapeutics, Inc. rights (a)(c)
|
3,192
|
24,163
|
|
SpringWorks Therapeutics, Inc. (a)(d)
|
971,999
|
47,880,671
|
|
Spyre Therapeutics, Inc. (a)
|
173,100
|
4,749,864
|
|
Spyre Therapeutics, Inc. (b)
|
98,104
|
2,557,375
|
|
Summit Therapeutics, Inc. (a)(d)
|
127,900
|
580,666
|
|
Tango Therapeutics, Inc. (b)
|
148,501
|
1,652,816
|
|
Tango Therapeutics, Inc. (a)
|
232,456
|
2,587,235
|
|
Taysha Gene Therapies, Inc. (a)
|
936,201
|
2,958,395
|
|
Tourmaline Bio, Inc.
|
21,300
|
826,866
|
|
Turnstone Biologics Corp.
|
53,100
|
242,136
|
|
UNITY Biotechnology, Inc. warrants 8/22/27 (a)
|
700,000
|
6,550
|
|
Vaxcyte, Inc. (a)
|
263,390
|
19,443,450
|
|
Vera Therapeutics, Inc. (a)
|
151,882
|
7,150,605
|
|
Vertex Pharmaceuticals, Inc. (a)
|
74,493
|
31,342,185
|
|
Verve Therapeutics, Inc. (a)(d)
|
68,600
|
1,169,630
|
|
Viking Therapeutics, Inc. (a)
|
1,072,700
|
82,651,535
|
|
Vor Biopharma, Inc. (a)
|
290,332
|
667,764
|
|
WuXi XDC Cayman, Inc.
|
107,129
|
249,026
|
|
Zai Lab Ltd. ADR (a)(d)
|
67,186
|
1,409,562
|
|
Zealand Pharma A/S (a)
|
214,200
|
20,623,331
|
|
Zentalis Pharmaceuticals, Inc. (a)
|
233,646
|
3,483,662
|
|
1,062,986,903
|
|||
Health Care Equipment & Supplies - 0.9%
|
|||
Abbott Laboratories
|
17,901
|
2,123,775
|
|
Blink Health LLC Series A1 (a)(b)(c)
|
8,589
|
407,290
|
|
Boston Scientific Corp. (a)
|
22,900
|
1,516,209
|
|
DexCom, Inc. (a)
|
48,184
|
5,544,533
|
|
Inspire Medical Systems, Inc. (a)
|
12,050
|
2,157,432
|
|
Insulet Corp. (a)
|
62,360
|
10,227,040
|
|
Intuitive Surgical, Inc. (a)
|
157,073
|
60,567,349
|
|
Medical Microinstruments, Inc. warrants 2/16/31 (a)(b)(c)
|
3,109
|
0
|
|
Novocure Ltd. (a)
|
1,541,474
|
23,599,967
|
|
Outset Medical, Inc. (a)
|
355,179
|
1,118,814
|
|
Penumbra, Inc. (a)
|
800
|
187,936
|
|
Presbia PLC (a)(c)
|
454,926
|
5
|
|
PROCEPT BioRobotics Corp. (a)
|
378,662
|
18,304,521
|
|
Shockwave Medical, Inc. (a)
|
71,167
|
18,565,335
|
|
144,320,206
|
|||
Health Care Providers & Services - 0.8%
|
|||
Alignment Healthcare, Inc. (a)
|
461,922
|
2,771,532
|
|
Guardant Health, Inc. (a)
|
68,700
|
1,305,300
|
|
Humana, Inc.
|
13,143
|
4,604,256
|
|
McKesson Corp.
|
17,300
|
9,020,393
|
|
The Oncology Institute, Inc. (a)(b)
|
377,375
|
709,465
|
|
UnitedHealth Group, Inc.
|
229,354
|
113,209,134
|
|
131,620,080
|
|||
Health Care Technology - 0.0%
|
|||
DNA Script (a)(b)(c)
|
85
|
9,558
|
|
DNA Script (a)(b)(c)
|
324
|
36,464
|
|
46,022
|
|||
Life Sciences Tools & Services - 0.4%
|
|||
10X Genomics, Inc. (a)
|
19,300
|
900,152
|
|
10X Genomics, Inc. Class B (a)(f)
|
570,857
|
26,624,770
|
|
Danaher Corp.
|
20,633
|
5,223,038
|
|
Gerresheimer AG
|
17,100
|
2,003,414
|
|
Thermo Fisher Scientific, Inc.
|
27,974
|
15,950,215
|
|
WuXi AppTec Co. Ltd. (H Shares) (f)
|
167,640
|
1,042,732
|
|
Wuxi Biologics (Cayman), Inc. (a)(f)
|
1,088,310
|
2,577,781
|
|
54,322,102
|
|||
Pharmaceuticals - 3.4%
|
|||
Adimab LLC (a)(b)(c)(e)
|
762,787
|
4,866,581
|
|
Adimab LLC (b)(c)(e)
|
762,787
|
14,576,860
|
|
Agomab Therapeutics SA warrants 10/10/33 (a)(b)(c)
|
10
|
0
|
|
Alto Neuroscience, Inc.
|
112,800
|
1,737,120
|
|
Arvinas Holding Co. LLC (a)
|
31,600
|
1,452,968
|
|
Bristol-Myers Squibb Co.
|
66,565
|
3,378,174
|
|
Dragonfly Therapeutics, Inc. (a)(b)(c)
|
126,113
|
2,287,690
|
|
Eli Lilly & Co.
|
455,100
|
342,999,768
|
|
Fulcrum Therapeutics, Inc. (a)
|
309,101
|
3,155,921
|
|
GH Research PLC (a)
|
178,200
|
1,582,416
|
|
Harmony Biosciences Holdings, Inc. (a)
|
380,923
|
12,227,628
|
|
Intra-Cellular Therapies, Inc. (a)
|
687,709
|
47,809,530
|
|
Merck & Co., Inc.
|
42,400
|
5,391,160
|
|
Neumora Therapeutics, Inc. (d)
|
134,500
|
2,371,235
|
|
Novo Nordisk A/S Series B sponsored ADR
|
391,600
|
46,901,932
|
|
Nuvation Bio, Inc. (a)
|
2,006,739
|
3,752,602
|
|
OptiNose, Inc. (a)
|
1,393,767
|
2,480,905
|
|
OptiNose, Inc. warrants (a)
|
206,400
|
112,265
|
|
Pfizer, Inc.
|
14,800
|
393,088
|
|
Pharvaris BV (a)
|
238,513
|
5,471,488
|
|
Pliant Therapeutics, Inc. (a)
|
301,400
|
4,783,218
|
|
Sienna Biopharmaceuticals, Inc. (a)(c)
|
589,618
|
6
|
|
Skyhawk Therapeutics, Inc. (a)(b)(c)
|
126,063
|
1,448,464
|
|
Structure Therapeutics, Inc. ADR
|
23,577
|
956,519
|
|
UCB SA
|
179,300
|
20,638,362
|
|
530,775,900
|
|||
TOTAL HEALTH CARE
|
1,924,071,213
|
||
INDUSTRIALS - 4.1%
|
|||
Aerospace & Defense - 0.9%
|
|||
AeroVironment, Inc. (a)
|
21,200
|
2,687,948
|
|
Lockheed Martin Corp.
|
38,450
|
16,465,828
|
|
Space Exploration Technologies Corp. Class A (a)(b)(c)
|
1,005,320
|
97,516,040
|
|
The Boeing Co. (a)
|
96,786
|
19,717,244
|
|
136,387,060
|
|||
Air Freight & Logistics - 0.1%
|
|||
Delhivery Private Ltd. (a)
|
646,600
|
3,690,288
|
|
United Parcel Service, Inc. Class B
|
19,084
|
2,829,394
|
|
6,519,682
|
|||
Building Products - 0.0%
|
|||
Builders FirstSource, Inc. (a)
|
15,300
|
2,986,254
|
|
Commercial Services & Supplies - 0.0%
|
|||
Veralto Corp.
|
6,777
|
585,668
|
|
Construction & Engineering - 0.2%
|
|||
Fluor Corp. (a)
|
387,200
|
14,248,960
|
|
Quanta Services, Inc.
|
44,400
|
10,723,044
|
|
24,972,004
|
|||
Electrical Equipment - 0.8%
|
|||
Eaton Corp. PLC
|
257,124
|
74,308,836
|
|
Emerson Electric Co.
|
123,249
|
13,169,156
|
|
Generac Holdings, Inc. (a)
|
114,800
|
12,916,148
|
|
Nextracker, Inc. Class A
|
31,100
|
1,749,064
|
|
NuScale Power Corp. (a)(d)
|
192,200
|
595,820
|
|
Schneider Electric SA
|
47,700
|
10,841,846
|
|
Vertiv Holdings Co.
|
117,500
|
7,945,350
|
|
121,526,220
|
|||
Ground Transportation - 1.3%
|
|||
Avis Budget Group, Inc.
|
332,200
|
35,890,888
|
|
Bird Global, Inc.:
|
|||
Stage 1 rights (a)(c)
|
1,142
|
0
|
|
Stage 2 rights (a)(c)
|
1,142
|
0
|
|
Stage 3 rights (a)(c)
|
1,142
|
0
|
|
Lyft, Inc. (a)
|
785,126
|
12,467,801
|
|
Old Dominion Freight Lines, Inc.
|
11,000
|
4,867,280
|
|
Uber Technologies, Inc. (a)
|
1,604,204
|
127,534,218
|
|
Union Pacific Corp.
|
117,061
|
29,697,205
|
|
210,457,392
|
|||
Industrial Conglomerates - 0.1%
|
|||
3M Co.
|
13,480
|
1,241,778
|
|
General Electric Co.
|
55,000
|
8,628,950
|
|
Honeywell International, Inc.
|
20,383
|
4,050,714
|
|
13,921,442
|
|||
Machinery - 0.4%
|
|||
Caterpillar, Inc.
|
107,860
|
36,020,926
|
|
Deere & Co.
|
53,852
|
19,658,673
|
|
Illinois Tool Works, Inc.
|
31,753
|
8,324,049
|
|
Ingersoll Rand, Inc.
|
50,144
|
4,579,652
|
|
68,583,300
|
|||
Passenger Airlines - 0.3%
|
|||
Delta Air Lines, Inc.
|
294,490
|
12,448,092
|
|
JetBlue Airways Corp. (a)
|
58,214
|
377,227
|
|
Ryanair Holdings PLC sponsored ADR
|
5,178
|
715,859
|
|
Southwest Airlines Co.
|
432,837
|
14,833,324
|
|
United Airlines Holdings, Inc. (a)
|
251,525
|
11,441,872
|
|
Wheels Up Experience, Inc.:
|
|||
rights (a)(c)
|
23,018
|
230
|
|
rights (a)(c)
|
23,018
|
0
|
|
rights (a)(c)
|
23,018
|
0
|
|
Wizz Air Holdings PLC (a)(f)
|
357,783
|
9,651,322
|
|
49,467,926
|
|||
Professional Services - 0.0%
|
|||
LegalZoom.com, Inc. (a)
|
173,600
|
2,152,640
|
|
Paylocity Holding Corp. (a)
|
15,997
|
2,697,254
|
|
4,849,894
|
|||
TOTAL INDUSTRIALS
|
640,256,842
|
||
INFORMATION TECHNOLOGY - 47.4%
|
|||
Communications Equipment - 0.7%
|
|||
Arista Networks, Inc. (a)
|
172,582
|
47,898,408
|
|
Ciena Corp. (a)
|
709,097
|
40,404,347
|
|
Infinera Corp. (a)(d)
|
3,377,953
|
16,957,324
|
|
105,260,079
|
|||
Electronic Equipment, Instruments & Components - 0.0%
|
|||
Coherent Corp. (a)
|
38,790
|
2,307,229
|
|
TE Connectivity Ltd.
|
1,241
|
178,158
|
|
2,485,387
|
|||
IT Services - 1.6%
|
|||
Accenture PLC Class A
|
108,900
|
40,813,542
|
|
Akamai Technologies, Inc. (a)
|
17,200
|
1,907,824
|
|
Cloudflare, Inc. (a)
|
934,781
|
92,113,320
|
|
IBM Corp.
|
135,495
|
25,070,640
|
|
Kyndryl Holdings, Inc. (a)
|
73,700
|
1,619,189
|
|
MongoDB, Inc. Class A (a)
|
25,141
|
11,252,609
|
|
Okta, Inc. (a)
|
131,881
|
14,150,831
|
|
Shopify, Inc. Class A (a)
|
512,590
|
39,163,289
|
|
Snowflake, Inc. (a)
|
87,525
|
16,479,207
|
|
Twilio, Inc. Class A (a)
|
6,100
|
363,499
|
|
X Holdings Corp. Class A (b)(c)
|
22,630
|
607,616
|
|
243,541,566
|
|||
Semiconductors & Semiconductor Equipment - 20.0%
|
|||
Advanced Micro Devices, Inc. (a)
|
724,136
|
139,417,904
|
|
Allegro MicroSystems LLC (a)
|
63,900
|
2,012,211
|
|
Applied Materials, Inc.
|
353,185
|
71,209,160
|
|
Arm Holdings Ltd. ADR (d)
|
63,300
|
8,927,832
|
|
ASML Holding NV (depository receipt)
|
16,985
|
16,164,285
|
|
Broadcom, Inc.
|
39,525
|
51,401,867
|
|
Cirrus Logic, Inc. (a)
|
214,066
|
19,655,540
|
|
Enphase Energy, Inc. (a)
|
24,100
|
3,060,941
|
|
First Solar, Inc. (a)
|
153,750
|
23,660,588
|
|
GlobalFoundries, Inc. (a)
|
87,400
|
4,778,158
|
|
Impinj, Inc. (a)
|
124,028
|
13,546,338
|
|
KLA Corp.
|
39,986
|
27,282,448
|
|
Lam Research Corp.
|
15,150
|
14,214,488
|
|
Lattice Semiconductor Corp. (a)
|
44,700
|
3,424,467
|
|
Marvell Technology, Inc.
|
901,341
|
64,590,096
|
|
Micron Technology, Inc.
|
151,331
|
13,712,102
|
|
Monolithic Power Systems, Inc.
|
29,200
|
21,025,168
|
|
NVIDIA Corp.
|
3,176,540
|
2,513,024,322
|
|
ON Semiconductor Corp. (a)
|
237,200
|
18,719,824
|
|
Qualcomm, Inc.
|
105,809
|
16,695,602
|
|
Silicon Laboratories, Inc. (a)
|
383,216
|
52,707,529
|
|
SiTime Corp. (a)
|
134,335
|
12,425,988
|
|
Taiwan Semiconductor Manufacturing Co. Ltd. sponsored ADR
|
117,168
|
15,076,007
|
|
Teradyne, Inc.
|
48,550
|
5,029,295
|
|
Texas Instruments, Inc.
|
100,494
|
16,815,661
|
|
Wolfspeed, Inc. (a)(d)
|
72,829
|
1,895,011
|
|
Xsight Labs Ltd. warrants 1/11/34 (a)(b)(c)
|
7,116
|
13,022
|
|
3,150,485,854
|
|||
Software - 15.1%
|
|||
Adobe, Inc. (a)
|
191,612
|
107,356,371
|
|
ASAPP, Inc. warrants 8/28/28 (a)(b)(c)
|
250,984
|
589,812
|
|
Atlassian Corp. PLC (a)
|
5,826
|
1,208,429
|
|
Autodesk, Inc. (a)
|
78,942
|
20,380,456
|
|
Bill Holdings, Inc. (a)
|
22,500
|
1,424,925
|
|
Clear Secure, Inc.
|
800
|
15,400
|
|
Confluent, Inc. (a)
|
372,200
|
12,606,414
|
|
CoreWeave, Inc. (b)(c)
|
27,752
|
10,105,891
|
|
Crowdstrike Holdings, Inc. (a)
|
124,733
|
40,432,202
|
|
Datadog, Inc. Class A (a)
|
114,980
|
15,115,271
|
|
DocuSign, Inc. (a)
|
17,100
|
910,917
|
|
Elastic NV (a)
|
55,994
|
7,492,557
|
|
Freshworks, Inc. (a)
|
324,800
|
6,638,912
|
|
HubSpot, Inc. (a)
|
49,067
|
30,363,150
|
|
Intuit, Inc.
|
73,394
|
48,652,149
|
|
Microsoft Corp.
|
2,955,236
|
1,222,403,819
|
|
Nutanix, Inc. Class A (a)
|
3,405,341
|
215,081,338
|
|
Oracle Corp.
|
1,107,104
|
123,641,375
|
|
Palantir Technologies, Inc. (a)
|
315,300
|
7,907,724
|
|
Palo Alto Networks, Inc. (a)
|
95,200
|
29,564,360
|
|
PTC, Inc. (a)
|
5,300
|
969,953
|
|
RingCentral, Inc. (a)
|
24,442
|
816,852
|
|
Salesforce, Inc.
|
908,549
|
280,578,102
|
|
Samsara, Inc. (a)
|
102,100
|
3,527,555
|
|
SentinelOne, Inc. (a)
|
29,100
|
819,747
|
|
ServiceNow, Inc. (a)
|
142,650
|
110,031,651
|
|
Stripe, Inc. Class B (a)(b)(c)
|
43,500
|
1,104,465
|
|
UiPath, Inc. Class A (a)
|
1,374,548
|
32,645,515
|
|
Workday, Inc. Class A (a)
|
55,732
|
16,421,991
|
|
Zoom Video Communications, Inc. Class A (a)
|
199,003
|
14,075,482
|
|
Zscaler, Inc. (a)
|
67,365
|
16,300,309
|
|
2,379,183,094
|
|||
Technology Hardware, Storage & Peripherals - 10.0%
|
|||
Apple, Inc.
|
7,521,328
|
1,359,480,036
|
|
Pure Storage, Inc. Class A (a)
|
4,082,886
|
214,963,948
|
|
Samsung Electronics Co. Ltd. (a)
|
73,513
|
4,040,582
|
|
Seagate Technology Holdings PLC
|
33,600
|
3,126,480
|
|
Super Micro Computer, Inc. (a)
|
1,600
|
1,385,792
|
|
1,582,996,838
|
|||
TOTAL INFORMATION TECHNOLOGY
|
7,463,952,818
|
||
MATERIALS - 0.4%
|
|||
Chemicals - 0.1%
|
|||
Albemarle Corp. (d)
|
40,700
|
5,610,495
|
|
Corteva, Inc.
|
250,000
|
13,380,000
|
|
Farmers Business Network, Inc. (a)(c)
|
21,002
|
45,574
|
|
Farmers Business Network, Inc. warrants 9/27/33 (a)(b)(c)
|
468,740
|
1,012,478
|
|
20,048,547
|
|||
Metals & Mining - 0.3%
|
|||
Barrick Gold Corp. (Canada)
|
406,100
|
5,921,762
|
|
Freeport-McMoRan, Inc.
|
1,143,900
|
43,250,859
|
|
49,172,621
|
|||
TOTAL MATERIALS
|
69,221,168
|
||
REAL ESTATE - 0.1%
|
|||
Equity Real Estate Investment Trusts (REITs) - 0.1%
|
|||
American Tower Corp.
|
49,198
|
9,783,514
|
|
Equinix, Inc.
|
4,000
|
3,555,280
|
|
13,338,794
|
|||
|
TOTAL COMMON STOCKS
(Cost $5,247,933,759)
|
15,453,249,910
|
||
Preferred Stocks - 1.7%
|
|||
Shares
|
Value ($)
|
||
Convertible Preferred Stocks - 1.7%
|
|||
COMMUNICATION SERVICES - 0.1%
|
|||
Interactive Media & Services - 0.1%
|
|||
ByteDance Ltd. Series E1 (a)(b)(c)
|
84,766
|
18,744,306
|
|
Reddit, Inc.:
|
|||
Series B(a)(b)(c)
|
37,935
|
1,110,357
|
|
Series E(a)(b)(c)
|
5,127
|
150,067
|
|
Series F(a)(b)(c)
|
40,428
|
1,183,328
|
|
21,188,058
|
|||
CONSUMER DISCRETIONARY - 0.1%
|
|||
Automobiles - 0.0%
|
|||
Rad Power Bikes, Inc.:
|
|||
Series A(a)(b)(c)
|
32,487
|
13,969
|
|
Series C(a)(b)(c)
|
127,831
|
94,595
|
|
Series D(a)(b)(c)
|
215,900
|
233,172
|
|
341,736
|
|||
Broadline Retail - 0.0%
|
|||
Meesho Series F (a)(b)(c)
|
62,461
|
3,191,132
|
|
Hotels, Restaurants & Leisure - 0.1%
|
|||
Discord, Inc. Series I (a)(b)(c)
|
1,400
|
351,876
|
|
MOD Super Fast Pizza Holdings LLC Series 3 (a)(b)(c)(e)
|
23,686
|
5,467,795
|
|
5,819,671
|
|||
Textiles, Apparel & Luxury Goods - 0.0%
|
|||
Canva, Inc.:
|
|||
Series A(b)(c)
|
924
|
985,594
|
|
Series A2(b)(c)
|
168
|
179,199
|
|
Freenome, Inc.:
|
|||
Series C(a)(b)(c)
|
190,858
|
1,349,366
|
|
Series D(a)(b)(c)
|
91,538
|
681,043
|
|
Laronde, Inc. Series B (a)(b)(c)
|
66,432
|
1,860,096
|
|
5,055,298
|
|||
TOTAL CONSUMER DISCRETIONARY
|
14,407,837
|
||
CONSUMER STAPLES - 0.0%
|
|||
Consumer Staples Distribution & Retail - 0.0%
|
|||
GoBrands, Inc.:
|
|||
Series G(a)(b)(c)
|
26,833
|
1,305,694
|
|
Series H(a)(b)(c)
|
21,372
|
1,309,035
|
|
2,614,729
|
|||
Food Products - 0.0%
|
|||
AgBiome LLC:
|
|||
Series C(a)(b)(c)
|
338,565
|
3
|
|
Series D(a)(b)(c)
|
126,371
|
44,230
|
|
Bowery Farming, Inc.:
|
|||
Series C1(a)(b)(c)
|
27,136
|
216,003
|
|
Series D1(b)(c)
|
14,699
|
78,199
|
|
338,435
|
|||
Tobacco - 0.0%
|
|||
JUUL Labs, Inc. Series E (a)(b)(c)
|
6,648
|
7,113
|
|
TOTAL CONSUMER STAPLES
|
2,960,277
|
||
FINANCIALS - 0.1%
|
|||
Financial Services - 0.1%
|
|||
Akeana Series C (b)(c)
|
100,800
|
1,282,176
|
|
Kartos Therapeutics, Inc. Series C (b)(c)
|
314,398
|
1,842,372
|
|
Paragon Biosciences Emalex Capital, Inc.:
|
|||
Series B(a)(b)(c)
|
198,234
|
2,313,391
|
|
Series C(a)(b)(c)
|
115,792
|
1,368,661
|
|
Series D1(a)(b)(c)
|
214,900
|
2,546,565
|
|
Series D2(a)(b)(c)
|
44,427
|
500,248
|
|
Saluda Medical, Inc.:
|
|||
Series D(b)(c)
|
109,988
|
1,353,952
|
|
Series E(b)(c)
|
289,149
|
2,495,356
|
|
Tenstorrent Holdings, Inc. Series C1 (b)(c)
|
40,678
|
2,463,053
|
|
16,165,774
|
|||
HEALTH CARE - 0.6%
|
|||
Biotechnology - 0.4%
|
|||
Altos Labs, Inc. Series B (a)(b)(c)
|
122,084
|
2,688,290
|
|
Ankyra Therapeutics Series B (a)(b)(c)
|
257,347
|
1,134,900
|
|
Asimov, Inc. Series B (a)(b)(c)
|
15,783
|
755,374
|
|
Bright Peak Therapeutics AG Series B (a)(b)(c)
|
239,403
|
397,409
|
|
Caris Life Sciences, Inc. Series D (a)(b)(c)
|
255,590
|
713,096
|
|
Castle Creek Biosciences, Inc.:
|
|||
Series B(a)(b)(c)
|
4,910
|
963,686
|
|
Series C(a)(b)(c)
|
2,570
|
599,016
|
|
Series D1(a)(b)(c)
|
4,460
|
940,703
|
|
Series D2(a)(b)(c)
|
1,412
|
264,792
|
|
Cellanome, Inc. Series B (b)(c)
|
274,637
|
2,051,538
|
|
Cleerly, Inc. Series C (a)(b)(c)
|
272,438
|
2,934,157
|
|
Deep Genomics, Inc. Series C (a)(b)(c)
|
129,534
|
1,418,397
|
|
Element Biosciences, Inc.:
|
|||
Series B(a)(b)(c)
|
250,956
|
3,008,962
|
|
Series C(a)(b)(c)
|
101,911
|
1,221,913
|
|
ElevateBio LLC Series C (a)(b)(c)
|
332,500
|
1,153,775
|
|
Fog Pharmaceuticals, Inc.:
|
|||
Series D(a)(b)(c)
|
247,595
|
1,512,805
|
|
Series E(b)(c)
|
114,541
|
713,590
|
|
Generate Biomedicines:
|
|||
Series B(a)(b)(c)
|
157,390
|
1,865,072
|
|
Series C(b)(c)
|
97,224
|
1,152,104
|
|
Genesis Therapeutics, Inc. Series B (b)(c)
|
402,516
|
2,056,857
|
|
Inscripta, Inc.:
|
|||
Series D(a)(b)(c)
|
308,833
|
846,202
|
|
Series E(a)(b)(c)
|
222,357
|
760,461
|
|
Intarcia Therapeutics, Inc. Series EE (a)(b)(c)
|
116,544
|
1
|
|
LifeMine Therapeutics, Inc. Series C (a)(b)(c)
|
1,780,790
|
3,686,235
|
|
National Resilience, Inc.:
|
|||
Series B(a)(b)(c)
|
251,448
|
12,094,649
|
|
Series C(a)(b)(c)
|
44,850
|
2,157,285
|
|
Odyssey Therapeutics, Inc.:
|
|||
Series B(a)(b)(c)
|
468,023
|
2,845,580
|
|
Series C(b)(c)
|
215,628
|
1,168,704
|
|
Quell Therapeutics Ltd. Series B (a)(b)(c)
|
760,965
|
1,537,149
|
|
Rapport Therapeutics, Inc. Series B (b)(c)
|
1,120,773
|
2,039,807
|
|
SalioGen Therapeutics, Inc. Series B (a)(b)(c)
|
8,766
|
587,322
|
|
Sonoma Biotherapeutics, Inc.:
|
|||
Series B(a)(b)(c)
|
481,325
|
1,434,349
|
|
Series B1(a)(b)(c)
|
256,702
|
859,952
|
|
T-Knife Therapeutics, Inc. Series B (a)(b)(c)
|
199,356
|
839,289
|
|
Treeline Biosciences:
|
|||
Series A(a)(b)(c)
|
289,700
|
2,372,643
|
|
Series A1(a)(b)(c)
|
143,637
|
1,205,114
|
|
61,981,178
|
|||
Health Care Equipment & Supplies - 0.1%
|
|||
Blink Health LLC:
|
|||
Series C(a)(b)(c)
|
197,068
|
9,344,965
|
|
Series C1(b)(c)
|
84,687
|
4,015,858
|
|
Kardium, Inc. Series D6 (a)(b)(c)
|
1,136,853
|
875,377
|
|
Medical Microinstruments, Inc. Series C (b)(c)
|
53,171
|
1,772,386
|
|
16,008,586
|
|||
Health Care Providers & Services - 0.0%
|
|||
Boundless Bio, Inc.:
|
|||
Series B(a)(b)(c)
|
616,102
|
579,136
|
|
Series C(b)(c)
|
2,572,461
|
1,877,897
|
|
Conformal Medical, Inc.:
|
|||
Series C(a)(b)(c)
|
240,750
|
1,102,635
|
|
Series D(b)(c)
|
55,260
|
291,773
|
|
Scorpion Therapeutics, Inc. Series B (a)(b)(c)
|
242,077
|
372,799
|
|
4,224,240
|
|||
Health Care Technology - 0.1%
|
|||
Aledade, Inc.:
|
|||
Series B1(a)(b)(c)
|
22,992
|
1,082,004
|
|
Series E1(a)(b)(c)
|
17,916
|
843,127
|
|
DNA Script:
|
|||
Series B(a)(b)(c)
|
4
|
499
|
|
Series C(a)(b)(c)
|
2,060
|
787,561
|
|
Omada Health, Inc. Series E (a)(b)(c)
|
435,062
|
1,735,897
|
|
PrognomIQ, Inc.:
|
|||
Series A5(a)(b)(c)
|
83,544
|
146,202
|
|
Series B(a)(b)(c)
|
198,721
|
486,866
|
|
Series C(a)(b)(c)
|
66,506
|
184,222
|
|
Wugen, Inc. Series B (a)(b)(c)
|
96,718
|
547,424
|
|
5,813,802
|
|||
Pharmaceuticals - 0.0%
|
|||
Agomab Therapeutics SA Series C (b)(c)
|
9,503
|
2,360,034
|
|
Galvanize Therapeutics Series B (a)(b)(c)
|
1,018,908
|
1,049,475
|
|
3,409,509
|
|||
TOTAL HEALTH CARE
|
91,437,315
|
||
INDUSTRIALS - 0.3%
|
|||
Aerospace & Defense - 0.3%
|
|||
Space Exploration Technologies Corp. Series G (a)(b)(c)
|
53,937
|
52,318,890
|
|
Construction & Engineering - 0.0%
|
|||
Beta Technologies, Inc.:
|
|||
Series A(a)(b)(c)
|
10,986
|
1,249,548
|
|
Series B, 6.00%(a)(b)(c)
|
17,147
|
2,163,608
|
|
3,413,156
|
|||
TOTAL INDUSTRIALS
|
55,732,046
|
||
INFORMATION TECHNOLOGY - 0.4%
|
|||
Electronic Equipment, Instruments & Components - 0.1%
|
|||
Enevate Corp. Series E (a)(b)(c)
|
814,561
|
684,231
|
|
Menlo Micro, Inc. Series C (a)(b)(c)
|
959,784
|
671,849
|
|
VAST Data Ltd.:
|
|||
Series A(b)(c)
|
87,399
|
1,321,473
|
|
Series A1(b)(c)
|
215,119
|
3,252,599
|
|
Series A2(b)(c)
|
247,456
|
3,741,535
|
|
Series B(b)(c)
|
196,904
|
2,977,188
|
|
Series C(b)(c)
|
5,740
|
86,789
|
|
Series E(b)(c)
|
188,154
|
2,844,888
|
|
15,580,552
|
|||
Semiconductors & Semiconductor Equipment - 0.1%
|
|||
Alif Semiconductor Series C (a)(b)(c)
|
43,548
|
829,589
|
|
Astera Labs, Inc.:
|
|||
Series A(a)(b)(c)
|
42,996
|
912,375
|
|
Series B(a)(b)(c)
|
7,321
|
155,352
|
|
Series C(a)(b)(c)
|
185,750
|
3,941,615
|
|
Series D(a)(b)(c)
|
145,945
|
3,096,953
|
|
Retym, Inc. Series C (b)(c)
|
202,413
|
1,694,197
|
|
SiMa.ai:
|
|||
Series B(a)(b)(c)
|
338,113
|
2,302,550
|
|
Series B1(a)(b)(c)
|
22,648
|
176,428
|
|
Xsight Labs Ltd.:
|
|||
Series D(a)(b)(c)
|
167,386
|
858,690
|
|
Series D1(b)(c)
|
23,720
|
175,765
|
|
14,143,514
|
|||
Software - 0.2%
|
|||
ASAPP, Inc. Series D (b)(c)
|
437,448
|
1,233,603
|
|
Bolt Technology OU Series E (a)(b)(c)
|
13,569
|
1,586,354
|
|
Databricks, Inc.:
|
|||
Series G(a)(b)(c)
|
53,226
|
4,367,193
|
|
Series H(a)(b)(c)
|
56,454
|
4,632,051
|
|
Dataminr, Inc. Series D (a)(b)(c)
|
442,241
|
5,638,573
|
|
Evozyne, Inc.:
|
|||
Series A(a)(b)(c)
|
101,400
|
1,713,660
|
|
Series B(b)(c)
|
63,838
|
1,092,268
|
|
Skyryse, Inc. Series B (a)(b)(c)
|
117,170
|
2,379,723
|
|
Stripe, Inc. Series H (a)(b)(c)
|
19,200
|
487,488
|
|
23,130,913
|
|||
Technology Hardware, Storage & Peripherals - 0.0%
|
|||
Lightmatter, Inc.:
|
|||
Series C(b)(c)
|
121,541
|
2,653,240
|
|
Series C2(b)(c)
|
19,091
|
494,457
|
|
3,147,697
|
|||
TOTAL INFORMATION TECHNOLOGY
|
56,002,676
|
||
MATERIALS - 0.1%
|
|||
Chemicals - 0.0%
|
|||
Farmers Business Network, Inc. Series G (a)(b)(c)
|
15,988
|
34,694
|
|
Metals & Mining - 0.1%
|
|||
Diamond Foundry, Inc. Series C (a)(b)(c)
|
355,446
|
8,900,368
|
|
TOTAL MATERIALS
|
8,935,062
|
||
UTILITIES - 0.0%
|
|||
Independent Power and Renewable Electricity Producers - 0.0%
|
|||
Redwood Materials:
|
|||
Series C(a)(b)(c)
|
16,253
|
646,544
|
|
Series D(b)(c)
|
6,752
|
268,595
|
|
915,139
|
|||
TOTAL CONVERTIBLE PREFERRED STOCKS
|
267,744,184
|
||
Nonconvertible Preferred Stocks - 0.0%
|
|||
CONSUMER DISCRETIONARY - 0.0%
|
|||
Automobiles - 0.0%
|
|||
Neutron Holdings, Inc. Series 1D (a)(b)(c)
|
5,678,726
|
185,126
|
|
Waymo LLC Series A2 (a)(b)(c)
|
10,731
|
559,085
|
|
744,211
|
|||
FINANCIALS - 0.0%
|
|||
Financial Services - 0.0%
|
|||
Circle Internet Financial Ltd. Series E (a)(b)(c)
|
137,221
|
3,644,590
|
|
HEALTH CARE - 0.0%
|
|||
Biotechnology - 0.0%
|
|||
Castle Creek Biosciences, Inc. Series A4 (a)(b)(c)
|
13,511
|
2,751,785
|
|
Pharmaceuticals - 0.0%
|
|||
Faraday Pharmaceuticals, Inc. Series B (a)(b)(c)
|
219,824
|
244,005
|
|
TOTAL HEALTH CARE
|
2,995,790
|
||
TOTAL NONCONVERTIBLE PREFERRED STOCKS
|
7,384,591
|
||
|
TOTAL PREFERRED STOCKS
(Cost $240,969,772)
|
275,128,775
|
||
Corporate Bonds - 0.1%
|
|||
Principal
Amount (h)
|
Value ($)
|
||
Convertible Bonds - 0.1%
|
|||
CONSUMER DISCRETIONARY - 0.1%
|
|||
Automobiles - 0.0%
|
|||
Neutron Holdings, Inc.:
|
|||
4% 5/22/27(b)(c)
|
857,900
|
1,162,540
|
|
4% 6/12/27(b)(c)
|
25,455
|
34,494
|
|
5.5% 10/29/26(b)(c)(i)
|
1,461,373
|
1,505,214
|
|
2,702,248
|
|||
Specialty Retail - 0.1%
|
|||
Wayfair LLC 0.625% 10/1/25
|
19,000,000
|
17,528,032
|
|
TOTAL CONSUMER DISCRETIONARY
|
20,230,280
|
||
HEALTH CARE - 0.0%
|
|||
Pharmaceuticals - 0.0%
|
|||
Galvanize Therapeutics 6% 2/28/27 (b)(c)
|
751,000
|
751,225
|
|
INFORMATION TECHNOLOGY - 0.0%
|
|||
Software - 0.0%
|
|||
Evozyne, Inc. 6% 9/13/28 pay-in-kind (b)(c)
|
1,006,858
|
1,080,358
|
|
MATERIALS - 0.0%
|
|||
Chemicals - 0.0%
|
|||
Farmers Business Network, Inc. 15% 9/28/25 (b)(c)
|
468,740
|
621,502
|
|
TOTAL CONVERTIBLE BONDS
|
22,683,365
|
||
Nonconvertible Bonds - 0.0%
|
|||
FINANCIALS - 0.0%
|
|||
Financial Services - 0.0%
|
|||
Ant International Co. Ltd. 3.55% 8/14/24 (b)(c)
|
64,650
|
64,734
|
|
|
TOTAL CORPORATE BONDS
(Cost $20,976,843)
|
22,748,099
|
||
Preferred Securities - 0.0%
|
|||
Principal
Amount (h)
|
Value ($)
|
||
CONSUMER DISCRETIONARY - 0.0%
|
|||
Automobiles - 0.0%
|
|||
Rad Power Bikes, Inc. 8% 12/31/25 (b)(c)
|
181,375
|
332,986
|
|
FINANCIALS - 0.0%
|
|||
Financial Services - 0.0%
|
|||
Tenstorrent Holdings, Inc. 5% 11/6/25 (b)(c)
|
753,700
|
811,961
|
|
HEALTH CARE - 0.0%
|
|||
Biotechnology - 0.0%
|
|||
Intarcia Therapeutics, Inc. 6% (b)(c)(j)
|
614,446
|
0
|
|
Health Care Equipment & Supplies - 0.0%
|
|||
Kardium, Inc. 0% (b)(c)(k)
|
1,612,660
|
1,222,396
|
|
TOTAL HEALTH CARE
|
1,222,396
|
||
INFORMATION TECHNOLOGY - 0.0%
|
|||
Electronic Equipment, Instruments & Components - 0.0%
|
|||
Enevate Corp. 6% (b)(c)(k)
|
42,358
|
44,086
|
|
|
TOTAL PREFERRED SECURITIES
(Cost $3,204,539)
|
2,411,429
|
||
Money Market Funds - 1.9%
|
|||
Shares
|
Value ($)
|
||
Fidelity Cash Central Fund 5.39% (l)
|
37,238,505
|
37,245,953
|
|
Fidelity Securities Lending Cash Central Fund 5.39% (l)(m)
|
257,910,731
|
257,936,522
|
|
|
TOTAL MONEY MARKET FUNDS
(Cost $295,182,475)
|
295,182,475
|
||
|
TOTAL INVESTMENT IN SECURITIES - 101.8%
(Cost $5,808,267,388)
|
16,048,720,688
|
NET OTHER ASSETS (LIABILITIES) - (1.8)%
|
(288,097,790)
|
NET ASSETS - 100.0%
|
15,760,622,898
|
(a)
|
Non-income producing
|
(b)
|
Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $468,312,324 or 3.0% of net assets.
|
(c)
|
Level 3 security
|
(d)
|
Security or a portion of the security is on loan at period end.
|
(e)
|
Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes.
|
(f)
|
Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $41,494,672 or 0.3% of net assets.
|
(g)
|
Security or a portion of the security purchased on a delayed delivery or when-issued basis.
|
(h)
|
Amount is stated in United States dollars unless otherwise noted.
|
(i)
|
Security initially issued at one coupon which converts to a higher coupon at a specified date. The rate shown is the rate at period end.
|
(j)
|
Non-income producing - Security is in default.
|
(k)
|
Security is perpetual in nature with no stated maturity date.
|
(l)
|
Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
|
(m)
|
Investment made with cash collateral received from securities on loan.
|
(n)
|
Equity security is subject to lock-up or market standoff agreement and valued at a discount to the market price of the equivalent equity security. As of period end, the total fair value of equity securities discounted due to contractual sale restrictions is $1,067,147 and all restrictions are set to expire on or before May 31, 2024. Under normal market conditions, there are no circumstances that could cause the restrictions to lapse.
|
Additional information on each restricted holding is as follows:
|
||
Security
|
Acquisition Date
|
Acquisition Cost ($)
|
Adimab LLC
|
9/17/14 - 6/05/15
|
11,733,914
|
AgBiome LLC Series C
|
6/29/18
|
2,144,369
|
AgBiome LLC Series D
|
9/03/21
|
749,101
|
Agomab Therapeutics SA warrants 10/10/33
|
10/03/23
|
0
|
Agomab Therapeutics SA Series C
|
10/03/23
|
2,074,942
|
Akeana Series C
|
1/23/24
|
1,286,289
|
Aledade, Inc. Series B1
|
5/07/21
|
880,380
|
Aledade, Inc. Series E1
|
5/20/22
|
892,475
|
Alif Semiconductor Series C
|
3/08/22
|
883,961
|
Altos Labs, Inc. Series B
|
7/22/22
|
2,337,713
|
Ankyra Therapeutics Series B
|
8/26/21
|
1,449,327
|
Ant International Co. Ltd. Class C
|
5/16/18
|
2,173,202
|
Ant International Co. Ltd. 3.55% 8/14/24
|
8/14/23
|
64,650
|
ASAPP, Inc. warrants 8/28/28
|
8/29/23
|
0
|
ASAPP, Inc. Series D
|
8/29/23
|
1,689,205
|
Asimov, Inc. Series B
|
10/29/21
|
1,462,779
|
Astera Labs, Inc. Series A
|
5/17/22
|
874,506
|
Astera Labs, Inc. Series B
|
5/17/22
|
148,902
|
Astera Labs, Inc. Series C
|
8/24/21
|
1,248,909
|
Astera Labs, Inc. Series D
|
5/17/22
|
2,968,386
|
Avidity Biosciences, Inc.
|
2/29/24
|
2,743,950
|
AVROBIO, Inc.
|
1/30/24
|
1,474,486
|
Beta Technologies, Inc. Series A
|
4/09/21
|
804,944
|
Beta Technologies, Inc. Series B, 6.00%
|
4/04/22
|
1,769,056
|
Blink Health LLC Series A1
|
12/30/20
|
232,676
|
Blink Health LLC Series C
|
11/07/19 - 7/14/21
|
7,523,268
|
Blink Health LLC Series C1
|
7/15/22 - 2/02/24
|
3,290,001
|
Bolt Technology OU Series E
|
1/03/22
|
3,525,179
|
Boundless Bio, Inc. Series B
|
4/23/21
|
831,738
|
Boundless Bio, Inc. Series C
|
4/05/23
|
1,800,723
|
Bowery Farming, Inc. Series C1
|
5/18/21
|
1,634,925
|
Bowery Farming, Inc. Series D1
|
10/25/23
|
138,881
|
Bowery Farming, Inc. warrants
|
10/25/23
|
0
|
Bright Peak Therapeutics AG Series B
|
5/14/21
|
935,108
|
ByteDance Ltd. Series E1
|
11/18/20
|
9,288,165
|
Canva, Inc. Series A
|
9/22/23
|
985,595
|
Canva, Inc. Series A2
|
9/22/23
|
179,199
|
Caris Life Sciences, Inc.
|
10/06/22
|
2,217,662
|
Caris Life Sciences, Inc. Series D
|
5/11/21
|
2,070,279
|
Castle Creek Biosciences, Inc. Series A4
|
9/29/16
|
4,471,547
|
Castle Creek Biosciences, Inc. Series B
|
10/09/18
|
2,022,184
|
Castle Creek Biosciences, Inc. Series C
|
12/09/19
|
1,058,455
|
Castle Creek Biosciences, Inc. Series D1
|
4/19/22
|
959,034
|
Castle Creek Biosciences, Inc. Series D2
|
6/28/21
|
242,100
|
Cellanome, Inc. Series B
|
1/08/24
|
2,057,031
|
Circle Internet Financial Ltd. Series E
|
5/11/21
|
2,227,100
|
Cleerly, Inc. Series C
|
7/08/22
|
3,209,483
|
Conformal Medical, Inc. Series C
|
7/24/20
|
882,846
|
Conformal Medical, Inc. Series D
|
5/26/23
|
280,702
|
CoreWeave, Inc.
|
11/29/23
|
8,599,235
|
Cyclerion Therapeutics, Inc.
|
4/02/19
|
2,229,495
|
Databricks, Inc. Series G
|
2/01/21
|
3,146,861
|
Databricks, Inc. Series H
|
8/31/21
|
4,148,473
|
Dataminr, Inc. Series D
|
2/18/15 - 3/06/15
|
5,638,573
|
Deep Genomics, Inc. Series C
|
7/21/21
|
1,878,398
|
Diamond Foundry, Inc. Series C
|
3/15/21
|
8,530,704
|
Dianthus Therapeutics, Inc. (unlisted)
|
5/03/23 - 1/22/24
|
2,504,591
|
Discord, Inc. Series I
|
9/15/21
|
770,874
|
DNA Script
|
12/17/21
|
327,504
|
DNA Script Series B
|
12/17/21
|
3,203
|
DNA Script Series C
|
10/01/21
|
1,791,891
|
Dragonfly Therapeutics, Inc.
|
12/19/19
|
3,336,950
|
Element Biosciences, Inc. Series B
|
12/13/19
|
1,315,160
|
Element Biosciences, Inc. Series C
|
6/21/21
|
2,094,954
|
ElevateBio LLC Series C
|
3/09/21
|
1,394,838
|
Enevate Corp. Series E
|
1/29/21
|
903,092
|
Enevate Corp. 6%
|
11/02/23
|
42,358
|
Epic Games, Inc.
|
7/13/20 - 7/30/20
|
6,785,000
|
Evozyne, Inc. Series A
|
4/09/21
|
2,278,458
|
Evozyne, Inc. Series B
|
9/14/23
|
988,851
|
Evozyne, Inc. 6% 9/13/28 pay-in-kind
|
9/14/23 - 12/13/23
|
1,006,858
|
Fanatics, Inc. Class A
|
8/13/20 - 10/24/22
|
6,002,415
|
Faraday Pharmaceuticals, Inc. Series B
|
12/30/19
|
288,996
|
Farmers Business Network, Inc. warrants 9/27/33
|
9/29/23
|
0
|
Farmers Business Network, Inc. Series G
|
9/15/21
|
993,779
|
Farmers Business Network, Inc. 15% 9/28/25
|
9/29/23
|
468,740
|
Fog Pharmaceuticals, Inc. Series D
|
11/17/22
|
2,664,890
|
Fog Pharmaceuticals, Inc. Series E
|
2/29/24
|
713,373
|
Freenome, Inc. Series C
|
8/14/20
|
1,262,201
|
Freenome, Inc. Series D
|
11/22/21
|
690,407
|
Galvanize Therapeutics Series B
|
3/29/22
|
1,764,020
|
Galvanize Therapeutics 6% 2/28/27
|
2/28/24
|
751,000
|
Generate Biomedicines Series B
|
11/02/21
|
1,865,072
|
Generate Biomedicines Series C
|
6/05/23
|
1,152,104
|
Genesis Therapeutics, Inc. Series B
|
8/10/23
|
2,055,891
|
GoBrands, Inc. Series G
|
3/02/21
|
6,700,664
|
GoBrands, Inc. Series H
|
7/22/21
|
8,302,821
|
Inscripta, Inc. Series D
|
11/13/20
|
1,411,367
|
Inscripta, Inc. Series E
|
3/30/21
|
1,963,412
|
Intarcia Therapeutics, Inc. Series EE
|
9/02/16
|
6,992,640
|
Intarcia Therapeutics, Inc. 6%
|
2/26/19
|
614,446
|
JUUL Labs, Inc. Class A
|
7/06/18 - 2/23/24
|
2,478,548
|
JUUL Labs, Inc. Series E
|
7/06/18
|
196,006
|
Kardium, Inc. Series D6
|
12/30/20
|
1,154,861
|
Kardium, Inc. 0%
|
12/30/20
|
1,612,660
|
Kartos Therapeutics, Inc. Series C
|
8/22/23
|
1,777,292
|
Korro Bio, Inc.
|
7/14/23
|
959,092
|
Laronde, Inc. Series B
|
8/13/21
|
1,860,096
|
LifeMine Therapeutics, Inc. Series C
|
2/15/22
|
3,626,739
|
Lightmatter, Inc. Series C
|
5/19/23
|
2,000,176
|
Lightmatter, Inc. Series C2
|
12/18/23
|
496,400
|
Medical Microinstruments, Inc. warrants 2/16/31
|
2/16/24
|
0
|
Medical Microinstruments, Inc. Series C
|
2/16/24
|
1,772,386
|
Meesho Series F
|
9/21/21
|
4,789,029
|
Menlo Micro, Inc. Series C
|
2/09/22
|
1,272,194
|
MOD Super Fast Pizza Holdings LLC Series 3
|
11/03/16 - 5/15/19
|
3,444,936
|
National Resilience, Inc. Series B
|
12/01/20
|
3,434,780
|
National Resilience, Inc. Series C
|
6/28/21
|
1,991,789
|
Neutron Holdings, Inc.
|
2/04/21
|
4,384
|
Neutron Holdings, Inc. Series 1D
|
1/25/19
|
1,377,091
|
Neutron Holdings, Inc. 4% 5/22/27
|
6/04/20
|
857,900
|
Neutron Holdings, Inc. 4% 6/12/27
|
6/12/20
|
25,455
|
Neutron Holdings, Inc. 5.5% 10/29/26
|
10/29/21 - 10/27/23
|
1,461,373
|
Odyssey Therapeutics, Inc. Series B
|
9/30/22
|
2,955,958
|
Odyssey Therapeutics, Inc. Series C
|
10/25/23
|
1,078,140
|
Omada Health, Inc. Series E
|
12/22/21
|
2,608,284
|
Paragon Biosciences Emalex Capital, Inc. Series B
|
9/18/19
|
2,020,004
|
Paragon Biosciences Emalex Capital, Inc. Series C
|
2/26/21
|
1,238,974
|
Paragon Biosciences Emalex Capital, Inc. Series D1
|
10/21/22
|
2,327,367
|
Paragon Biosciences Emalex Capital, Inc. Series D2
|
5/18/22
|
382,943
|
PrognomIQ, Inc. Series A5
|
8/20/20
|
50,461
|
PrognomIQ, Inc. Series B
|
9/11/20
|
454,100
|
PrognomIQ, Inc. Series C
|
2/16/22
|
203,508
|
Quell Therapeutics Ltd. Series B
|
11/24/21
|
1,438,224
|
Rad Power Bikes, Inc.
|
1/21/21
|
1,202,019
|
Rad Power Bikes, Inc. warrants 10/6/33
|
10/06/23
|
0
|
Rad Power Bikes, Inc. Series A
|
1/21/21
|
156,712
|
Rad Power Bikes, Inc. Series C
|
1/21/21
|
616,636
|
Rad Power Bikes, Inc. Series D
|
9/17/21
|
2,069,142
|
Rad Power Bikes, Inc. 8% 12/31/25
|
10/06/23
|
181,375
|
Rapport Therapeutics, Inc. Series B
|
8/11/23
|
1,879,839
|
Reddit, Inc. Series B
|
7/26/17
|
538,544
|
Reddit, Inc. Series E
|
5/18/21
|
217,765
|
Reddit, Inc. Series F
|
8/11/21
|
2,498,224
|
Redwood Materials Series C
|
5/28/21
|
770,449
|
Redwood Materials Series D
|
6/02/23
|
322,313
|
Retym, Inc. Series C
|
5/17/23 - 6/20/23
|
1,575,137
|
SalioGen Therapeutics, Inc. Series B
|
12/10/21
|
928,004
|
Saluda Medical, Inc. warrants 1/20/27
|
1/20/22
|
0
|
Saluda Medical, Inc. Series D
|
1/20/22
|
1,402,995
|
Saluda Medical, Inc. Series E
|
4/06/23
|
2,334,531
|
Scholar Rock Holding Corp. warrants 12/31/25
|
6/17/22
|
0
|
Scorpion Therapeutics, Inc. Series B
|
1/08/21
|
585,688
|
SiMa.ai Series B
|
5/10/21
|
1,733,641
|
SiMa.ai Series B1
|
4/25/22
|
160,595
|
Skyhawk Therapeutics, Inc.
|
5/21/21
|
2,069,954
|
Skyryse, Inc. Series B
|
10/21/21
|
2,891,752
|
Sonoma Biotherapeutics, Inc. Series B
|
7/26/21
|
951,243
|
Sonoma Biotherapeutics, Inc. Series B1
|
7/26/21
|
760,993
|
Space Exploration Technologies Corp. Class A
|
10/16/15 - 4/06/17
|
8,987,844
|
Space Exploration Technologies Corp. Series G
|
1/20/15
|
4,177,960
|
Spyre Therapeutics, Inc.
|
6/22/23 - 12/07/23
|
966,634
|
Stripe, Inc. Class B
|
5/18/21
|
1,745,585
|
Stripe, Inc. Series H
|
3/15/21
|
770,400
|
T-Knife Therapeutics, Inc. Series B
|
6/30/21
|
1,150,045
|
Tango Therapeutics, Inc.
|
8/09/23
|
764,780
|
Tenstorrent Holdings, Inc. Series C1
|
4/23/21
|
2,418,540
|
Tenstorrent Holdings, Inc. 5% 11/6/25
|
11/06/23
|
753,700
|
The Beauty Health Co.
|
12/08/20
|
5,538,280
|
The Oncology Institute, Inc.
|
6/28/21
|
3,773,750
|
Tory Burch LLC
|
5/14/15
|
17,582,037
|
Treeline Biosciences Series A
|
7/30/21 - 10/27/22
|
2,267,627
|
Treeline Biosciences Series A1
|
10/27/22
|
1,236,758
|
VAST Data Ltd. Series A
|
11/28/23
|
961,389
|
VAST Data Ltd. Series A1
|
11/28/23
|
2,366,309
|
VAST Data Ltd. Series A2
|
11/28/23
|
2,722,016
|
VAST Data Ltd. Series B
|
11/28/23
|
2,165,944
|
VAST Data Ltd. Series C
|
11/28/23
|
63,140
|
VAST Data Ltd. Series E
|
11/28/23
|
4,139,388
|
Waymo LLC Series A2
|
5/08/20
|
921,441
|
Wugen, Inc. Series B
|
7/09/21
|
750,038
|
X Holdings Corp. Class A
|
10/27/21
|
1,326,759
|
Xsight Labs Ltd. warrants 1/11/34
|
1/11/24
|
0
|
Xsight Labs Ltd. Series D
|
2/16/21
|
1,338,418
|
Xsight Labs Ltd. Series D1
|
1/11/24
|
189,665
|
Affiliate
|
Value,
beginning
of period ($)
|
Purchases ($)
|
Sales
Proceeds ($)
|
Dividend
Income ($)
|
Realized
Gain (loss) ($)
|
Change in
Unrealized
appreciation
(depreciation) ($)
|
Value,
end
of period ($)
|
% ownership,
end
of period
|
Fidelity Cash Central Fund 5.39%
|
13,027,623
|
364,275,344
|
340,057,014
|
584,689
|
-
|
-
|
37,245,953
|
0.1%
|
Fidelity Securities Lending Cash Central Fund 5.39%
|
212,772,443
|
261,849,841
|
216,685,762
|
347,923
|
-
|
-
|
257,936,522
|
0.8%
|
Total
|
225,800,066
|
626,125,185
|
556,742,776
|
932,612
|
-
|
-
|
295,182,475
|
|